Latest Sanofi Press Releases and News | Sanofi
Sep 25, 2024 · Stay informed with the latest Sanofi press releases and news updates. Discover new developments in healthcare and pharmaceuticals with Sanofi.
Sanofi pushes ahead with €20bn consumer healthcare spin-off
Jun 2, 2024 · The move makes Sanofi the latest Big Pharma company to seek to separate low-margin, consumer businesses from divisions focused on innovative new medicines that offer higher returns.
Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend
2 days ago · The consumer health unit, known as Opella, is set to be valued at around €15 billion ($16.3 billion), Bloomberg News has reported. Sanofi confirmed last week it’s in talks to sell a 50% ...
Sanofi US News
Sep 27, 2024 · Sanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation play in the disease progression through Dupixent, a first-in-class biologic, and the investigation of itepekimab.
Press Release: Sanofi and Novavax announce co-exclusive ...
May 10, 2006 · Starting in 2025, Sanofi will book sales of Novavax’s adjuvanted COVID-19 vaccine and will support certain R&D, regulatory, and commercial expenses. Novavax will receive tiered double-digit percentage royalty payments on sales by Sanofi of COVID-19 vaccines and flu-COVID-19 combination vaccines.
Sanofi Enters Next Chapter of Play to Win Strategy | Sanofi
Oct 27, 2005 · Sanofi today provided a comprehensive update regarding its Play to Win strategy. This strategy continues to focus on the critical goals of executing transformative medicine and vaccines launches, driving agile and efficient resource deployment and …
Press Room - Sanofi US News
5 days ago · Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA. Read more. Sep 13, 2024.